Your browser doesn't support javascript.
COVID-19 hot-spot strategy: a special innovation in pandemic response, Oyo State Nigeria.
Bassey, Enya Bassey; Kazadi Mulomb, Walter; Ahmed Khedr, Ahmed Mohamed; Mpazanje, Rex Gadama; Onyibe, Rosemary Ifeoma; Kolude, Olufunmilola Olawumi; Marcus, Oluwadare; Alawale, Oluwabukola; Ogunlaja, Omotunde; Oluwatobi, Adeoluwa Iyanda; Adedamola, Ayodeji Tella; Olayiwola, Suliat Olanike; Ladipo, Taiwo Olabode.
  • Bassey EB; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria. bassey69@yahoo.com.
  • Kazadi Mulomb W; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Ahmed Khedr AM; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Mpazanje RG; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Onyibe RI; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Kolude OO; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Marcus O; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Alawale O; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Ogunlaja O; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Oluwatobi AI; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Adedamola AT; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Olayiwola SO; World Health Organization (WHO) Nigeria Country Office, UN House, Plot 617/618, Diplomatic Drive, Central Business District, PMB 2861, Garki, Abuja, Nigeria.
  • Ladipo TO; Oyo State COVID-19 Emergency Operation Center, Ministry of Health, Yemetu, Ibadan, Nigeria.
BMC Public Health ; 22(1): 233, 2022 02 04.
Article in English | MEDLINE | ID: covidwho-1736399
ABSTRACT

BACKGROUND:

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into a pandemic. Oyo state, Nigeria with a population of 9,233,010, recorded the first case of COVID-19 on the 12th of March 2020 and it is among the highest contributing States to the nation's burden of the disease with 3267 confirmed cases, including 40 deaths as of date, with an overall test positivity rate of 18.1%, far higher compared to the National average within a limited period from recorded index case. A 'Hotspot strategy' was designed by the Presidential Task Force on COVID-19 and Oyo State was selected to implement the strategy through upscaling case detection, isolation and treatment, quarantine of contacts and strengthening public health and social measures.

METHODS:

We used a descriptive cross-sectional survey of 3 identified hotspot Local Government Areas (LGAs) in Oyo State using mobile phones under Surveillance, Outbreak Response Management and Analysis System (SORMAS) platform to collect data from October to December 2020. Interventions comprised of enhanced active case search, contact line listing, contact investigation, and contact follow-up as well as to facilitate data collection and entry, community sensitization and management of alert/rumors. Baseline information and that after the 3-month period was then analyzed with the descriptive statistics presented.

RESULTS:

The implementation of the hotspot strategy was shown to have had a major impact in Irepo LGA, where more than a 100% increase in samples tested, confirmed cases, contacts listed and contacts followed were recorded, while there were no significance changes noticed in Ibadan North and Lagelu LGAs. However, test positivity rates among contacts were found to be quite high in Ibadan North LGA (48%), compared to the other two, even though Lagelu LGA (5.7%) tested more contacts than Ibadan North.

CONCLUSION:

The observed increase in number of samples tested, cases confirmed, contact listed and investigated as well as test positivity rate in the 3 LGAs after the intervention implies that the hotspot strategy can be said to have contributed positively to the sensitivity of COVID-19 surveillance in Oyo State, Nigeria. This implies that strengthening this 'hotspot strategy' may be a key area of focus to improve COVID-19 surveillance sensitivity and response and in turn may help in breaking the transmission and bringing the pandemic to a halt.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: Africa Language: English Journal: BMC Public Health Journal subject: Public Health Year: 2022 Document Type: Article Affiliation country: S12889-022-12675-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: Africa Language: English Journal: BMC Public Health Journal subject: Public Health Year: 2022 Document Type: Article Affiliation country: S12889-022-12675-2